| MeSH term | MeSH ID | Detail |
|---|---|---|
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Diabetes Mellitus, Type 1 | D003922 | 56 associated lipids |
| Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
| Asthma | D001249 | 52 associated lipids |
| Cardiovascular Diseases | D002318 | 24 associated lipids |
| Hypercholesterolemia | D006937 | 91 associated lipids |
| Thrombosis | D013927 | 49 associated lipids |
| Cerebral Hemorrhage | D002543 | 13 associated lipids |
| Brain Ischemia | D002545 | 89 associated lipids |
11-dehydro-txb2
Cross Reference
Introduction
To understand associated biological information of 11-dehydro-txb2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with 11-dehydro-txb2?
11-dehydro-txb2 is suspected in Risk factor, cardiovascular, Acute coronary syndrome, thrombocytosis, Chronic ischemic heart disease NOS, Diabetes Mellitus, Diabetes Mellitus, Non-Insulin-Dependent and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 11-dehydro-txb2
PubChem Associated disorders and diseases
What pathways are associated with 11-dehydro-txb2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with 11-dehydro-txb2?
There are no associated biomedical information in the current reference collection.
What functions are associated with 11-dehydro-txb2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with 11-dehydro-txb2?
There are no associated biomedical information in the current reference collection.
What genes are associated with 11-dehydro-txb2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with 11-dehydro-txb2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with 11-dehydro-txb2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid:27137142 | ||||
| pmid:28911508 | ||||
| pmid:28139223 | ||||
| pmid:27693274 | ||||
| pmid:26385032 | ||||
| pmid:24126290 | ||||
| pmid:25759102 | ||||
| pmid:27815971 | ||||
| pmid:27784132 | ||||
| pmid:25589198 | ||||
| pmid:25466142 | ||||
| pmid:28005558 | ||||
| pmid:24803308 | ||||
| pmid:24763965 | ||||
| pmid:27389698 | ||||
| pmid:27769511 | ||||
| pmid:25288566 | ||||
| pmid:25808116 | ||||
| pmid:24907931 | ||||
| pmid:27609361 | ||||
| pmid:27481134 | ||||
| pmid:27237049 | ||||
| pmid:27098431 | ||||
| pmid:25669623 | ||||
| pmid:26095809 | ||||
| pmid: | ||||
| Satoh K et al. | Plasma 11-dehydrothromboxane B2: a reliable indicator of platelet hyperfunction in patients with ischemic stroke. | 1991 | Acta Neurol. Scand. | pmid:2017905 |
| Vainio M et al. | Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders. | 2004 | Acta Obstet Gynecol Scand | pmid:15548142 |
| Hayashi M et al. | The levels of five markers of hemostasis and endothelial status at different stages of normotensive pregnancy. | 2002 | Acta Obstet Gynecol Scand | pmid:11966476 |
| Leonhardt A et al. | Reference intervals and developmental changes in urinary prostanoid excretion in healthy newborns, infants and children. | 1992 | Acta Paediatr. | pmid:1511190 |
| Chen HI et al. | Effects of exercise training on the biosynthesis of prostacyclin and thromboxane in rats. | 1993 | Acta Physiol. Scand. | pmid:8452036 |
| Signore C et al. | Markers of oxidative stress and systemic vasoconstriction in pregnant women drinking > or =48 g of alcohol per day. | 2008 | Alcohol. Clin. Exp. Res. | pmid:18715278 |
| Oosaki R et al. | Urinary leukotriene E4 and 11-dehydrothromboxane B2 in patients with aspirin-sensitive asthma. | 1997 | Allergy | pmid:9188934 |
| Mita H et al. | Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma. | 2001 | Allergy | pmid:11703219 |
| Ikonomidis I et al. | Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment. | 2005 | Am. Heart J. | pmid:15894964 |
| Rebuzzi AG et al. | Importance of reperfusion on thromboxane A2 metabolite excretion after thrombolysis. | 1992 | Am. Heart J. | pmid:1539506 |
| Faraday N et al. | Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population. | 2006 | Am. J. Cardiol. | pmid:16950183 |
| Yasu T et al. | Effects of aspirin DL-lysine on thrombin generation in unstable angina pectoris. | 1993 | Am. J. Cardiol. | pmid:8480641 |
| Milani M et al. | Effects of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia. | 1995 | Am. J. Cardiol. | pmid:7604798 |
| Shen H et al. | Aspirin Resistance in healthy drug-naive men versus women (from the Heredity and Phenotype Intervention Heart Study). | 2009 | Am. J. Cardiol. | pmid:19660620 |
| Fukushima H et al. | Mechanisms underlying early development of pulmonary vascular obstructive disease in Down syndrome: An imbalance in biosynthesis of thromboxane A2 and prostacyclin. | 2010 | Am. J. Med. Genet. A | pmid:20583254 |
| Schiff E et al. | Reduction of thromboxane A2 synthesis in pregnancy by polyunsaturated fatty acid supplements. | 1993 | Am. J. Obstet. Gynecol. | pmid:8420313 |
| Van Assche FA et al. | Increased thromboxane formation in diabetic pregnancy as a possible contributor to preeclampsia. | 1993 | Am. J. Obstet. Gynecol. | pmid:8420355 |
| Fitzgerald DJ et al. | Increased thromboxane biosynthesis in normal pregnancy is mainly derived from platelets. | 1987 | Am. J. Obstet. Gynecol. | pmid:3618681 |
| Reinke M | Monitoring thromboxane in body fluids: a specific ELISA for 11-dehydrothromboxane B2 using a monoclonal antibody. | 1992 | Am. J. Physiol. | pmid:1590375 |
| Llinás MT et al. | Role of COX-2-derived metabolites in regulation of the renal hemodynamic response to norepinephrine. | 2001 | Am. J. Physiol. Renal Physiol. | pmid:11592955 |
| Ciabattoni G et al. | In vivo lipid peroxidation and platelet activation in cystic fibrosis. | 2000 | Am. J. Respir. Crit. Care Med. | pmid:11029317 |
| Kataoka M et al. | A long-acting prostacyclin agonist with thromboxane inhibitory activity for pulmonary hypertension. | 2005 | Am. J. Respir. Crit. Care Med. | pmid:16192456 |
| Davì G et al. | Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. The Chronic Obstructive Bronchitis and Haemostasis Study Group. | 1997 | Am. J. Respir. Crit. Care Med. | pmid:9412557 |
| Praticò D et al. | Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. | 1998 | Am. J. Respir. Crit. Care Med. | pmid:9847257 |
| Baltzer WI et al. | Measurement of urinary 11-dehydro-thromboxane B2 excretion in dogs with gastric dilatation-volvulus. | 2006 | Am. J. Vet. Res. | pmid:16426215 |
| Hoh CM et al. | Evaluation of effects of low-dose aspirin administration on urinary thromboxane metabolites in healthy dogs. | 2011 | Am. J. Vet. Res. | pmid:21801060 |
| Lupinetti MD et al. | Thromboxane biosynthesis in allergen-induced bronchospasm. Evidence for platelet activation. | 1989 | Am. Rev. Respir. Dis. | pmid:2508524 |
| Kumlin M et al. | Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics. | 1992 | Am. Rev. Respir. Dis. | pmid:1320824 |
| Schweer H et al. | Tandem mass spectrometric determination of 11-dehydrothromboxane B2, an index metabolite of thromboxane B2 in plasma and urine. | 1987 | Anal. Biochem. | pmid:3674365 |
| Cavalca V et al. | Simultaneous quantification of 8-iso-prostaglandin-F(2alpha) and 11-dehydro thromboxane B(2) in human urine by liquid chromatography-tandem mass spectrometry. | 2010 | Anal. Biochem. | pmid:19825360 |
| Lawson JA et al. | Long-lived enzymatic metabolites of thromboxane B2 in the human circulation. | 1986 | Anal. Biochem. | pmid:3087234 |
| Hayashi Y et al. | Immunoaffinity purification of 11-dehydro-thromboxane B2 from human urine and plasma for quantitative analysis by radioimmunoassay. | 1990 | Anal. Biochem. | pmid:2372112 |
| Riutta A et al. | Solid-phase extraction of urinary 11-dehydrothromboxane B2 for reliable determination with radioimmunoassay. | 1992 | Anal. Biochem. | pmid:1519756 |
| Di Minno MN et al. | Increased platelet reactivity in Klinefelter men: something new to consider. | 2015 | Andrology | pmid:26216452 |
| Carroll RC et al. | A comparison of VerifyNowR with PlateletMappingR--detected aspirin resistance and correlation with urinary thromboxane. | 2013 | Anesth. Analg. | pmid:23302970 |
| Foulon I et al. | Increased in vivo production of thromboxane in patients with sickle cell disease is accompanied by an impairment of platelet functions to the thromboxane A2 agonist U46619. | 1993 | Arterioscler. Thromb. | pmid:8443146 |
| Bröijersén A et al. | No influence of simvastatin treatment on platelet function in vivo in patients with hypercholesterolemia. | 1997 | Arterioscler. Thromb. Vasc. Biol. | pmid:9081681 |
| Davi G et al. | In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. | 1997 | Arterioscler. Thromb. Vasc. Biol. | pmid:9409316 |
| Davì G et al. | Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation. | 2005 | Arterioscler. Thromb. Vasc. Biol. | pmid:15472127 |
| Stein CM et al. | Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. | 1996 | Arthritis Rheum. | pmid:8670323 |
| Cracowski JL et al. | Enhanced in vivo lipid peroxidation in scleroderma spectrum disorders. | 2001 | Arthritis Rheum. | pmid:11352247 |
| Ferro D et al. | Determinants of enhanced thromboxane biosynthesis in patients with systemic lupus erythematosus. | 1999 | Arthritis Rheum. | pmid:10616019 |
| Jörres A et al. | Urinary excretion of thromboxane and markers for renal injury in patients undergoing cardiopulmonary bypass. | 1994 | Artif Organs | pmid:7527629 |
| Takayama K et al. | Changes in endothelial vasoactive substances under recombinant human erythropoietin therapy in hemodialysis patients. | 1991 Jul-Sep | ASAIO Trans | pmid:1836334 |
| Falco A et al. | Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. | 2005 | Atherosclerosis | pmid:16285996 |
| Markuszewski L et al. | Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin? | 2006 | Basic Clin. Pharmacol. Toxicol. | pmid:16635110 |
| Calapai G et al. | Cardiovascular biomarkers in groups of established smokers after a decade of smoking. | 2009 | Basic Clin. Pharmacol. Toxicol. | pmid:19175368 |
| Liu TF et al. | [Correlation between the level of the urinary 11-dehydrothromboxane B2 and the clinical efficacy of aspirin in patients with type 2 diabetes and coronary artery disease]. | 2015 | Beijing Da Xue Xue Bao | pmid:26679651 |
| Varma D et al. | Comparison of UHPLC and HPLC methods for the assay of prostanoids: "are the methods equivalent in terms of accuracy and precision?". | 2011 | Bioanalysis | pmid:21510759 |
| Ciabattoni G et al. | Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man. | 1989 | Biochim. Biophys. Acta | pmid:2752040 |
| Patrignani P et al. | Fractional conversion of thromboxane A2 and B2 to urinary 2,3-dinor-thromboxane B2 and 11-dehydrothromboxane B2 in the cynomolgus monkey. | 1989 | Biochim. Biophys. Acta | pmid:2752041 |
| Wu P et al. | Purification and characterization of an NAD(+)-dependent dehydrogenase that catalyzes the oxidation of thromboxane B2 at C-11 from porcine liver. Development and application of 11-dehydro-thromboxane B2 radioimmunoassay to enzyme assay. | 1990 | Biochim. Biophys. Acta | pmid:2223826 |
| Lorenz RL et al. | A critical evaluation of urinary immunoreactive thromboxane: feasibility of its determination as a potential vascular risk indicator. | 1989 | Biochim. Biophys. Acta | pmid:2597697 |
| Ciabattoni G et al. | Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urine. | 1987 | Biochim. Biophys. Acta | pmid:3567215 |
| Lüdicke F et al. | A Japanese cross-sectional multicentre study of biomarkers associated with cardiovascular disease in smokers and non-smokers. | 2015 | Biomarkers | pmid:26616146 |
| Milani M et al. | Effects of two different HMG-CoA reductase inhibitors on thromboxane production in type IIA hypercholesterolemia. | 1996 | Biomed. Pharmacother. | pmid:8952866 |
| Dragani A et al. | The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. | 2010 | Blood | pmid:19887674 |
| Landolfi R et al. | Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo. | 1992 | Blood | pmid:1327286 |
| Wang ZY et al. | Comparative study of platelet activation markers in diabetes mellitus patients complicated by cerebrovascular disease. | 2001 | Blood Coagul. Fibrinolysis | pmid:11685040 |
| Dharmasaroja PA and Sae-Lim S | Effects of different doses, enteric-coated preparation of aspirin, and sex on urinary 11-dehydrothromboxane B2 in healthy volunteers. | 2010 | Blood Coagul. Fibrinolysis | pmid:20689403 |
| Bridges AB et al. | Circadian variation of endothelial cell function, red blood cell deformability and dehydro-thromboxane B2 in healthy volunteers. | 1991 | Blood Coagul. Fibrinolysis | pmid:1932530 |
| Dharmasaroja PA et al. | Aspirin nonresponders in patients with ischaemic stroke. | 2013 | Blood Coagul. Fibrinolysis | pmid:23429255 |
| Warner JH et al. | Adaptive regression modeling of biomarkers of potential harm in a population of U.S. adult cigarette smokers and nonsmokers. | 2010 | BMC Med Res Methodol | pmid:20233412 |
| Wallén NH et al. | Effects of treatment with oral isosorbide dinitrate on platelet function in vivo; a double-blind placebo-controlled study in patients with stable angina pectoris. | 1994 | Br J Clin Pharmacol | pmid:7946939 |
| Floyd CN et al. | Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin-resistant but not aspirin-sensitive subjects. | 2014 | Br J Clin Pharmacol | pmid:25099258 |
| Martinuzzo ME et al. | Increased lipid peroxidation correlates with platelet activation but not with markers of endothelial cell and blood coagulation activation in patients with antiphospholipid antibodies. | 2001 | Br. J. Haematol. | pmid:11564073 |
| Coppola A et al. | Reduced in vivo oxidative stress following 5-methyltetrahydrofolate supplementation in patients with early-onset thrombosis and 677TT methylenetetrahydrofolate reductase genotype. | 2005 | Br. J. Haematol. | pmid:16173969 |
| Helgason CM et al. | Platelet aggregation and recruitment with aspirin-clopidogrel therapy. | 2008 | Cerebrovasc. Dis. | pmid:18349532 |
| Dippel DW et al. | What is the lowest dose of aspirin for maximum suppression of in vivo thromboxane production after a transient ischemic attack or ischemic stroke? | 2004 | Cerebrovasc. Dis. | pmid:15026612 |
| Ferretti A and Flanagan VP | Mass spectrometric evidence for the anomalous chemical behavior of 11-dehydrothromboxane B2. | 1995 | Chem. Phys. Lipids | pmid:7586090 |
| Tanaka S et al. | High dose of inhaled fluticasone reduces high levels of urinary leukotriene E4 in the early morning in mild and moderate nocturnal asthma. | 2003 | Chest | pmid:14605047 |
| Obase Y et al. | Effects of cysteinyl-leukotriene receptor antagonist, thromboxane A2 receptor antagonist, and thromboxane A2 synthetase inhibitor on antigen-induced bronchoconstriction in patients with asthma. | 1998 | Chest | pmid:9792572 |
| Kurokawa K et al. | Circadian characteristics of urinary leukotriene E(4) in healthy subjects and nocturnal asthmatic patients. | 2001 | Chest | pmid:11742908 |
| Obase Y et al. | Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients. | 2002 | Chest | pmid:11796443 |